CMS Extends Medicare’s Short-Term Bridge Program for GLP-1 Obesity Drug Coverage
KFF Medicare
Extending the short-term GLP-1 Bridge program is good news for eligible Medicare beneficiaries because it provides the certainty of obesity drug coverage at a $50 copay for a longer duration, but fede
pharminent
April 23, 2026 (Last updated: April 24, 2026)
KFF Medicare
Extending the short-term GLP-1 Bridge program is good news for eligible Medicare beneficiaries because it provides the certainty of obesity drug coverage at a $50 copay for a longer duration, but fede